Asia Pacific Elastography Imaging Market Size, Share & Trends Analysis Report By End-use (Imaging Centers, Hospitals), By Application (General Imaging, Cardiology), By Modality, By Country, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The Asia Pacific elastography imaging market size was estimated at USD 552.80 million in 2024 and is expected to grow at a CAGR of 7.92% from 2025 to 2030. The rising prevalence of chronic diseases is increasing the demand for non-invasive diagnostic techniques, while technological advancements in ultrasound and MRI elastography are enhancing imaging accuracy and accessibility. The expansion of healthcare infrastructure and diagnostic centers, particularly in countries such as China and India, is further fueling market growth. In addition, the growing geriatric population is contributing to a higher incidence of chronic diseases, necessitating advanced diagnostic solutions. Medical tourism in countries such as India and Thailand, coupled with government initiatives promoting early disease detection and preventive healthcare, is boosting adoption.

The increasing prevalence of chronic disorders such as liver disease, cancer, musculoskeletal conditions, and cardiovascular diseases is driving the demand for advanced imaging technologies in the Asia Pacific region. Elastography is highly efficient in assessing tissue stiffness, detecting fibrosis, and distinguishing between benign and malignant lesions, making it a preferred non-invasive alternative to traditional biopsy methods. Its ability to provide real-time, accurate, and early disease detection enhances clinical decision-making, particularly in the diagnosis of liver fibrosis, breast cancer, and thyroid disorders. As healthcare providers prioritize early diagnosis and precision medicine, the adoption of elastography is growing across hospitals, diagnostic centers, and research institutes in the Asia Pacific region.

The growing medical tourism industry in the Asia Pacific region is expected to be a significant driver of elastography imaging market growth. In September 2024, China’s Ministry of Commerce, National Health Commission, and National Medical Products Administration issued a joint circular allowing foreign investors to operate hospitals in major cities such as Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen, and Hainan province. According to the South China Morning Post, China also plans to permit fully foreign-owned hospitals and allow foreign investment.

However, India already has a well-established medical tourism industry, attracting patients with affordable yet high-quality healthcare services, China is in the early stages of developing its medical tourism sector but is expected to witness a rapid boom. India has positioned itself as a global leader in medical tourism, whereas China is actively expanding its healthcare capabilities. This rising influx of international patients seeking cost-effective, high-quality diagnostic and treatment options is expected to fuel demand for advanced imaging technologies, including elastography, as hospitals and diagnostic centers aim to enhance their service offerings.

Market Concentration & Characteristics

The Asia Pacific elastography imaging industry is experiencing significant growth, owing to the rising prevalence of chronic diseases such as liver fibrosis, cancer, and musculoskeletal disorders, which necessitate advanced diagnostic solutions. Technological advancements in ultrasound and MRI elastography, including AI integration and portable imaging devices, are enhancing diagnostic accuracy and accessibility. The expansion of healthcare infrastructure, particularly in emerging economies such as China and India, along with government initiatives promoting early disease detection, is further driving adoption.

Industry players in the Asia Pacific elastography imaging industry are adopting various strategies to maintain their competitive edge, such as expanding their product portfolios, forming strategic partnerships, and fostering collaborations. For instance, in November 2024, Canon Medical Systems launched the Vantage Galan 3T / Supreme Edition, an advanced MRI system equipped with all Canon-manufactured components. This system integrates an innovative Real-time platform and precision Japan-made magnet technology, designed to enhance imaging performance, streamline operational workflows, and improve patient comfort. Such innovations help companies differentiate themselves in the competitive industry, positioning them to cater to the growing demand for high-quality, efficient imaging solutions.

The Asia Pacific elastography imaging industry is experiencing a high degree of innovation, driven by continuous advancements in imaging technologies. This includes the integration of AI to improve diagnostic accuracy, the development of portable elastography devices for point-of-care use, and the enhancement of ultrasound and MRI elastography techniques.

The Asia Pacific elastography imaging industry is seeing a significant rise in partnerships and collaborations, as companies work to broaden their service offerings and reach a wider customer base. In July 2024, Philips, a global leader in health technology, today announced that it has partnered with Star Imaging, Pune to launch a first-of-its-kind MRI Training School in India.

Regulations play a significant role in shaping the Asia Pacific elastography imaging industry, influencing industry entry, product approvals, and adoption rates. Stringent medical device regulations in countries such as China and Japan require extensive clinical validation and compliance with national healthcare standards, which can slow down the introduction of new elastography technologies.

Market players are increasingly focusing on product launches to expand their offerings and strengthen their industry presence. For instance, in June 2023, Mindray announced its entry into the transient elastography industry with the launch of the Hepatus 6 Diagnostic Ultrasound System. This innovative system combines transient elastography and diagnostic ultrasound into a single device, making it ideally suited for non-invasive detection, diagnosis, and evaluation of liver disease.

Industry players are actively pursuing expansion strategies to broaden their reach and enhance service offerings. For instance, in June 2024, Esaote Group expanded its presence in India by establishing a new manufacturing facility in New Delhi. The facility, managed by its subsidiary Esaote Asia Pacific Diagnostic Private Limited, aims to strengthen local production capabilities, improve supply chain efficiency, and cater to the growing demand for advanced imaging solutions in the region. Such expansions reflect the industry's focus on localizing production, reducing costs, and enhancing accessibility to cutting-edge elastography imaging technology. 

Modality Insights

The ultrasound segment held the largest market share in 2024 and is further expected to grow at a fastest CAGR of 8.03% from 2025 to 2030. This is owing to its high efficiency in liver fibrosis assessment, increasing preference for point-of-care diagnostics, and technological advancements such as AI integration and portable ultrasound devices. In addition, the growing burden of chronic liver diseases and cancer, along with the expansion of healthcare infrastructure in emerging economies, has further driven demand for ultrasound-based elastography imaging.

The MRI segment is also expected to grow over the forecast period. Its high precision in soft tissue characterization and ability to provide detailed, quantitative assessment of tissue stiffness. The increasing prevalence of chronic liver diseases, musculoskeletal disorders, and cancer is fueling demand for MRI elastography. In addition, technological advancements such as AI-powered imaging, improved magnetic resonance sequences, and enhanced patient comfort features are making MRI elastography more accessible and efficient. As healthcare providers in the Asia Pacific region continue to invest in advanced diagnostic capabilities, the adoption of MRI elastography is expected to rise significantly.

Application Insights

The general imaging segment dominated the market by capturing a share of more than 32.5% in 2024. This dominance is attributed to the widespread application of elastography in routine diagnostic imaging, particularly in the assessment of liver fibrosis, breast lesions, thyroid disorders, and musculoskeletal conditions. The increasing demand for non-invasive diagnostic techniques, coupled with technological advancements in ultrasound and MRI elastography, has further boosted adoption. In addition, the expansion of healthcare facilities, growing awareness of early disease detection, and improving reimbursement policies have contributed to the segment’s dominance.

The breast segment is expected to grow at the fastest CAGR of 8.99% over the forecast period. This is owing to the rising incidence of breast cancer and the increasing demand for non-invasive, early diagnostic solutions. According to the International Agency for Research on Cancer (IARC), in 2022, approximately 985,817 cancer cases were reported in Asia. Furthermore, the five-year prevalence of cancer in the region is projected to reach 3,197,043 cases. Elastography imaging plays a crucial role in differentiating benign from malignant breast lesions, reducing the need for unnecessary biopsies. Advancements in ultrasound and MRI elastography, coupled with growing awareness of breast cancer screening programs, are further driving adoption. In addition, government initiatives, expanding healthcare infrastructure, and improved reimbursement policies in countries such as China, India, and Japan are contributing to the rapid growth of this segment.

End Use Insights

Hospital segment dominated the market with a share of nearly 39.7% in 2024, driven by the increasing number of hospital-based imaging centers, the rising adoption of advanced diagnostic technologies, and the growing patient influx for chronic disease diagnosis and treatment. Hospitals are the primary healthcare facilities equipped with advanced elastography imaging systems, enabling comprehensive disease assessment, particularly for liver fibrosis, cancer, and musculoskeletal disorders. In addition, government initiatives to expand healthcare infrastructure, rising medical tourism, and improving reimbursement policies have further fueled the dominance of the hospital segment in the Asia Pacific elastography imaging market.

The imaging centers segment is anticipated to experience the fastest growth of 8.31% over the forecast period, driven by the increasing demand for cost-effective and specialized diagnostic services, as well as the rising preference for outpatient imaging solutions. Imaging centers offer faster appointment scheduling, lower costs compared to hospitals, and access to advanced elastography imaging technologies, making them an attractive option for patients.

Country Insights

China Elastography Imaging Market Trends

China elastography imaging market dominated the Asia Pacific region with a market share of 26.21% in 2024. China accounts for the largest population in the region and faces a growing burden of chronic diseases, such as liver disease, cancer, and cardiovascular disorders, which is driving the demand for advanced diagnostic technologies such as elastography. The country's rapid healthcare infrastructure development, increasing investments in medical technologies, and the expansion of diagnostic centers have further contributed to its market leadership.

Japan Elastography Imaging Market Trends

The elastography imaging market in Japan accounted for a market share of 19.25% in 2024. Japan's advanced healthcare infrastructure, coupled with its technologically advanced medical imaging systems, plays a significant role in driving market growth. The country is known for its high-quality healthcare services and strong emphasis on early diagnosis and preventive healthcare. In addition, the aging population in Japan is contributing to the growing need for diagnostic technologies such as elastography, particularly for chronic conditions such as liver disease and cancer.

India Elastography Imaging Market Trends

The India elastography imaging market is expected to grow over the forecast period. This growth is driven by increasing healthcare investments, particularly in advanced diagnostic technologies, and the growing burden of chronic diseases such as liver disease, cancer, and musculoskeletal disorders. The rise in medical tourism in India, which attracts patients seeking affordable, high-quality healthcare services, further boosts the demand for elastography imaging.

Key Asia Pacific Elastography Imaging Company Insights

Key players in the Asia Pacific elastography imaging industry are crucial in shaping market dynamics by actively working to expand their market share and customer base. These leading companies are investing in research and development to create and introduce new products that meet the evolving demands of healthcare providers and patients. In addition to innovation, they are pursuing strategic initiatives such as partnerships, collaborations, mergers, and acquisitions. These efforts enable them to enhance product offerings, strengthen their market presence, broaden their reach, and tap into new customer segments, ultimately fueling overall market growth.

Recent Developments

• In August 2024, Siemens Healthineers announced that it has received FDA clearance for the ACUSON Origin, an advanced cardiovascular ultrasound system enhanced with artificial intelligence (AI) capabilities.

• In February 2024, GE Healthcare unveiled a strategic collaboration with Biofourmis, with the aim of improving continuity of care by facilitating safe, effective, and accessible care in the home, thus supporting patients beyond the hospital environment. This collaboration harnesses the collective expertise of two industry leaders to expand and deliver innovative care-at-home solutions at scale.

• In January 2024, Canon Medical Systems introduced Aplio me, an innovative shared-service ultrasound system designed to address the varied needs of routine users across a broad range of clinical environments.

Asia Pacific Elastography Imaging Market Report Scope

Asia Pacific Elastography Imaging Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the Asia Pacific elastography market report on the basis of modality, application, end use, and country:

• Modality Outlook (Revenue, USD Million, 2018 - 2030)

  • Ultrasound

  • Magnetic Resonance Imaging

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • General Imaging

  • Hepatology

  • Breast

  • Cardiology

  • Nephrology

  • Orthopedic and Musculoskeletal

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Imaging Centers

  • Other End Use

• Country Outlook (Revenue, USD Million, 2018 - 2030)

  • China

  • Japan

  • India

  • Thailand

  • South Korea

  • Australia